NCT00881842View on ClinicalTrials.gov

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Influenza
Interventions
BIOLOGICAL

Trivalent influenza subunit vaccine Influvac

3x 15mcg HA per 0.5 ml,trivalent one injection at Day 1

Trial Locations (2)

3890

Site Reference ID/Investigator# 59243, Tessenderlo

22769

Site Reference ID/Investigator# 59244, Hamburg

Sponsors

Lead Sponsor

Abbott Biologicals
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Abbott Biologicals

INDUSTRY

NCT00881842 - Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season | Biotech Hunter | Biotech Hunter